4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-20-009818
Director sold 8,000 shares at an average $23.50 ($188,000)
- Director acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CHESS ROBERT Director | 2020-02-12 | Option exercise | −8,000 | $9.24 | $73,920 | 284,973 | D: show line 1 in the form |
| CHESS ROBERT Director | 2020-02-12 | Sale | −4,401 | $23.32 | $102,631 | 280,572 | D: show line 2 in the form |
| CHESS ROBERT Director | 2020-02-12 | Sale | −3,599 | $23.72 | $85,368 | 276,973 | D: show line 3 in the form |
| Open-market sales · 8,000 sh · avg $23.50 · $188,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| CHESS ROBERT Director | 2020-02-12 | Option exercise · Stock Option | −8,000 | 32,000 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…